Moderna Paid the US More Than Enough for Covid Shot Partnership, Executive Says

Moderna Inc. plans to tell US lawmakers that it more than adequately compensated the government for its role in a Covid-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

The US invested $1.5 billion to help fund Moderna’s clinical trials. In exchange, the company gave the government a discount on the shots that resulted in about $3 billion less in sales than rival Pfizer, Moderna President Stephen Hoge said Monday.